Drug intelligence / Profile preview

loprazolam

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

Loprazolam is a short-acting imidazobenzodiazepine used primarily for the short-term treatment of insomnia, including difficulty falling asleep and frequent nocturnal awakenings. It acts as a positive allosteric modulator of the Gamma aminobutyric acid type A receptor (GABA-A receptor) complex by binding to the benzodiazepine site on alpha subunit-containing GABA-A receptors, enhancing the inhibitory effect of GABA neurotransmission. This results in sedative, hypnotic, anxiolytic, anticonvulsant, amnesic, and muscle relaxant properties. Loprazolam is recommended only for short-term use due to risks such as dependence and withdrawal symptoms. It is not FDA-approved but has been marketed in several countries under various brand names[1][2][7].

Brand names
DormonoctHavlaneSoninSomnovit
Other names
triazulenoneloprazolam mesylate
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on loprazolam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on loprazolam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call